Who is Organovo?
- We participate in attractive and growing markets with critical unmet needs
- We benefit from favorable competitive dynamics and a first mover advantage
- We’re a technology leader with a strong IP portfolio
- We’re leveraging our technology platform to build a robust product and service platform across the preclinical safety, efficacy and disease modeling and therapeutic tissues markets
|Recent Investor NewsInvestor Events|
|There are currently no events scheduled.||Latest Tweets|